Andy Sassine insider trades: Arcturus Therapeutics Holdings (ARCT) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Andy reports to the SEC
and 1 more company
Open-market buys and sales
20 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Aug 15, 2025 | ARCT | ↑ Buy | 1,238 | $16.56 | $20K | Direct | Aug 19, 2025 (4d) |
| Jun 12, 2024 | ARCT | ↓ Sell | 50,000 | $32.03 | $1.6M | Direct | Jun 14, 2024 (2d) |
| Feb 8, 2022 | ICAD | ↓ Sell10b5-1 | 20,000 | $5.38 | $108K | Direct | Feb 9, 2022 (1d) |
| Jan 7, 2022 | ICAD | ↓ Sell10b5-1 | 20,000 | $6.13 | $123K | Direct | Jan 11, 2022 (4d) |
| Dec 7, 2021 | ICAD | ↓ Sell10b5-1 | 20,000 | $7.00 | $140K | Direct | Dec 8, 2021 (1d) |
| Nov 9, 2021 | ICAD | ↓ Sell10b5-1 | 20,000 | $10.60 | $212K | Direct | Nov 10, 2021 (1d) |
| Oct 7, 2021 | ICAD | ↓ Sell10b5-1 | 20,000 | $10.49 | $210K | Direct | Oct 8, 2021 (1d) |
| Sep 14, 2021 | ICAD | ↓ Sell10b5-1 | 20,000 | $10.88 | $218K | Direct | Sep 15, 2021 (1d) |
| Sep 9, 2020 | ICAD | ↓ Sell10b5-1 | 20,000 | $9.44 | $189K | Direct | Sep 9, 2020 (0d) |
| Aug 7, 2020 | ICAD | ↓ Sell10b5-1 | 20,000 | $10.29 | $206K | Direct | Aug 10, 2020 (3d) |
| Jul 14, 2020 | ICAD | ↓ Sell10b5-1 | 20,000 | $9.50 | $190K | Direct | Jul 15, 2020 (1d) |
| Jun 10, 2020 | ARCT | ↑ Buy | 5,000 | $29.74 | $149K | Direct | Jun 10, 2020 (0d) |
| Dec 5, 2019 | ARCT | ↑ Buy | 5,649 | $9.73 | $55K | Direct | Dec 9, 2019 (4d) |
| Dec 3, 2019 | ARCT | ↑ Buy | 10,000 | $10.00 | $100K | Direct | Dec 5, 2019 (2d) |
| Aug 23, 2019 | ARCT | ↑ Buy | 10,000 | $10.90 | $109K | Direct | Aug 26, 2019 (3d) |
| Mar 10, 2017 | GEMP | ↑ Buy | 21,119 | $9.47 | $200K | Direct | Mar 14, 2017 (4d) |
| Jun 5, 2014 | ACFN | ↑ Buy | 232,684 | $1.73 | $402K | Direct | Jun 6, 2014 (1d) |
| Dec 2, 2013 | ACFN | ↑ Buy | 12,724 | $3.57 | $45K | Direct | Dec 4, 2013 (2d) |
| Nov 27, 2013 | ACFN | ↑ Buy | 22,158 | $3.73 | $83K | Direct | Dec 2, 2013 (5d) |
| Oct 18, 2013 | ACFN | ↑ Buy | 6,988 | $3.25 | $23K | Direct | Oct 18, 2013 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Andy Sassine's insider trades
Andy Sassine is Chief Financial Officer at Arcturus Therapeutics Holdings (ARCT). Since Oct 18, 2013, Andy has reported 10 open-market purchases worth $1.2M and 10 sales worth $3.2M on SEC Form 4. There have been no open-market trades in the last 12 months.
9 sales (50% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.
Their filings also include grants and awards (53 filings), conversions (3 filings), shares returned to the company (2 filings), other transactions (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ARCT insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.